Does the content and source credibility of health and risk messages related to nicotine vaping products have an impact on harm perception and behavioural intentions? A systematic review.

Comparative risk e-cigarettes health communication health messages health warning nicotine

Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
12 2021
Historique:
revised: 02 11 2020
received: 12 06 2020
accepted: 24 02 2021
pubmed: 23 3 2021
medline: 16 11 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

To systematically review the literature on (i) whether and how various risk messages about nicotine vaping products (NVPs) alter harm perception and behavioural intentions of smokers and non-smokers and (ii) how trust in sources of NVP risk communication affects message reception and behavioural intentions. Seven electronic databases and reference lists of relevant articles were searched for articles published up to April 2020. Experimental and quasi-experimental studies on message effects and cross-sectional studies on source credibility were included. The Newcastle-Ottawa Scale and the Evidence Project Risk of Bias Tool were used to assess the quality of observational and intervention studies, respectively. For each outcome variable, we indicated whether there was an effect (as a 'yes' or 'no') and used effect direction plots to display information on the direction of effects. Nicotine addiction messages resulted in greater health and addiction risk perceptions, relative risk messages comparing the health risks of NVPs to cigarette smoking increased the perception that NVPs are less harmful than combustible cigarettes, and a nicotine fact sheet corrected misperceptions of nicotine and NVPs. Smokers' intention to purchase, try or switch to NVPs was higher when exposed to a relative risk message and lower when exposed to nicotine addiction warnings. Trust in NVP risk information from public health agencies was associated with lower odds of; (i) NVP use and (ii) perceiving NVPs as less harmful, whereas those who trusted information from NVP companies were more likely to perceive NVPs as less harmful than combustible cigarettes. Relative risk messages may help improve the accuracy of harm perceptions of nicotine vaping products and increase smokers' intentions to quit smoking and/or to switch to vaping, although the literature is nascent.

Identifiants

pubmed: 33751707
doi: 10.1111/add.15473
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3290-3303

Subventions

Organisme : Medical Research Council
ID : MR/S037519/1
Pays : United Kingdom

Informations de copyright

© 2021 Society for the Study of Addiction.

Références

World Health Organization. WHO Report on the Global Tobacco Epidemic. WHO. https://www.who.int/tobacco/global_report/en/. Published 2019. Accessed May 1, 2020.
Benowitz N. L. Nicotine addiction. N Engl J Med 2010; 362: 2295-2303.
Benowitz N. L., Burbank A. D. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med 2016; 26: 515-523.
Hartmann-Boyce J., Chepkin S. C., Ye W., Bullen C., Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev 2018; 5(5): CD000146.
Abrams D. B., Glasser A. M., Villanti A. C., Pearson J. L., Rose S., Niaura R. S. Managing nicotine without smoke to save lives now: evidence for harm minimization. Prev Med 2018; 117: 88-97.
Hatsukami D. K., Ebbert J. O., Feuer R. M., Stepanov I., Hecht S. S. Changing smokeless tobacco products: new tobacco-delivery systems. Am J Prev Med 2007; 33: S368-S378.
Brewer N. T., Jeong M., Hall M. G., Baig S. A., Mendel J. R., Lazard A. J., et al. Impact of e-cigarette health warnings on motivation to vape and smoke. Tob Control 2019; 28: e64-e70.
Wackowski O. A., Sontag J. M., Hammond D., O'connor R. J., Ohman-Strickland P. A., Strasser A. A., et al. The impact of E-cigarette warnings, warning themes and inclusion of relative harm statements on young Adults' E-cigarette perceptions and use intentions. Int J Environ Res Public Health 2019; 16: 184.
Huang J., Feng B., Weaver S. R., Pechacek T. F., Slovic P., Eriksen M. P. Changing perceptions of harm of e-cigarette vs cigarette use among adults in 2 US national surveys from 2012 to 2017. JAMA Netw Open 2019; 2: e191047.
Borland R., Cooper J., McNeill A., O'Connor R., Cummings K. M. Trends in beliefs about the harmfulness and use of stop-smoking medications and smokeless tobacco products among cigarettes smokers: findings from the ITC four-country survey. Harm Reduct J 2011; 8: 21.
Wilson S., Partos T., McNeill A., Brose L. S. Harm perceptions of e-cigarettes and other nicotine products in a UK sample. Addiction 2019; 114: 879-888.
Villanti A. C., Byron M. J., Mercincavage M. Pacek LR. Misperceptions of nicotine and nicotine reduction: the importance of public education to maximize the benefits of a nicotine reduction standard. Nicotine Tob Res 2019; 21: S88-S90.
McNeill A., Brose L. S., Calder R., Bauld L., Robson D. Evidence review of ecigarettes and heated tobacco products 2018. A report commissioned by Public Health England. London: Public Health England; 2018.
Royal College of Physicians Nicotine without smoke-tobacco harm reduction. London: RCP; 2016.
National Academies of Sciences Engineering and Medicine Public Health Consequences of E-Cigarettes. Washington DC: The National Academies Press; 2018.
Noar S. M., Hall M. G., Francis D. B., Ribisl K. M., Pepper J. K., Brewer N. T. Pictorial cigarette pack warnings: a meta-analysis of experimental studies. Tob Control 2016; 25: 341-354.
Monárrez-Espino J., Liu B., Greiner F., Bremberg S., Galanti R. Systematic review of the effect of pictorial warnings on cigarette packages in smoking behavior. Am J Public Health 2014; 104: e11-e30.
Noar S. M., Francis D. B., Bridges C., Sontag J. M., Brewer N. T., Ribisl K. M. Effects of strengthening cigarette pack warnings on attention and message processing: a systematic review. Journal Mass Commun Q 2017; 94: 416-442.
Partos T. R., Borland R., Yong H.-H., Thrasher J., Hammond D. Cigarette packet warning labels can prevent relapse: findings from the international tobacco control 4-country policy evaluation cohort study. Tob Control 2013; 22: e43-e50.
Noar S. M., Francis D. B., Bridges C., Sontag J. M., Ribisl K. M., Brewer N. T. The impact of strengthening cigarette pack warnings: systematic review of longitudinal observational studies. Soc Sci Med 2016; 164: 118-129.
Emery L. F., Romer D., Sheerin K. M., Jamieson K. H., Peters E. Affective and cognitive mediators of the impact of cigarette warning labels. Nicotine Tob Res 2014; 16: 263-269.
Hammond D., Fong G. T., Borland R., Cummings K. M., McNeill A., Driezen P. Text and graphic warnings on cigarette packages: findings from the international tobacco control four country study. Am J Prev Med 2007; 32: 202-209.
Cornacchione Ross J., Noar S. M., Sutfin E. L. Systematic review of health communication for non-cigarette tobacco products. Health Commun 2019; 34: 361-369.
Andrews J. C., Mays D., Netemeyer R. G., Burton S., Kees J. Effects of e-cigarette health warnings and modified risk ad claims on adolescent e-cigarette craving and susceptibility. Nicotine Tob Res 2019; 21: 792-798.
Berry C., Burton S. Reduced-risk warnings versus the US FDA-mandated addiction warning: the effects of e-cigarette warning variations on health risk perceptions. Nicotine Tob Res 2019; 21: 979-984.
Keating D. M. Extending efforts to move cigarette and e-cigarette beliefs: message exposure and belief structures. J Health Commun 2018; 23: 956-966.
Mumford E. A., Pearson J. L., Villanti A. C. Evans DW. E-cigarette beliefs: testing a relative risk message in a representative US sample. Tob Regul Sci 2019; 5: 115-123.
Pepper J. K., Byron M. J., Ribisl K. M., Brewer N. T. How hearing about harmful chemicals affects smokers' interest in dual use of cigarettes and e-cigarettes. Prev Med 2017; 96: 144-148.
Schmidt A. M., Ranney L. M., Pepper J. K., Goldstein A. O. Source credibility in tobacco control messaging. Tob Regul Sci 2016; 2: 31-37.
Moher D., Liberati A., Tetzlaff J., Altman D. G. The PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
Wells G. A., Shea B., O'Connell D., Peterson J., Welch V., Losos M., et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital research institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Published 2008. Accessed November 23, 2020.
Kennedy C. E., Fonner V. A., Armstrong K. A., Denison J. A., Yeh P. T., O'Reilly K. R., et al. The evidence project risk of bias tool: assessing study rigor for both randomized and non-randomized intervention studies. Syst Rev 2019; 8: 3.
Francis D. B., Hall M. G., Noar S. M., Ribisl K. M., Brewer N. T. Systematic review of measures used in pictorial cigarette pack warning experiments. Nicotine Tob Res 2017; 19: 1127-1137.
Mays D., Villanti A., Niaura R. S., Lindblom E. N., Strasser A. A. The effects of varying electronic cigarette warning label design features on attention, recall, and product perceptions among young adults. Health Commun 2019; 34: 317-324.
Yang B., Popova L. Communicating risk differences between electronic and combusted cigarettes: the role of the FDA-mandated addiction warning and a nicotine fact sheet. Tob Control 2019; 29: 663-671.
Cox S., Frings D., Ahmed R., Dawkins L. Messages matter: the tobacco products directive nicotine addiction health warning versus an alternative relative risk message on smokers' willingness to use and purchase an electronic cigarette. Addict Behav Rep 2018; 8: 136-139.
Villanti A. C., West J. C., Mays D., Donny E. C., Cappella J. N., Strasser A. A. Impact of brief nicotine messaging on nicotine-related beliefs in a US sample. Am J Prev Med 2019; 57: e135-e142.
Berry C., Burton S., Howlett E. Are cigarette smokers', E-cigarette users', and dual users' health-risk beliefs and responses to advertising influenced by addiction warnings and product type? Nicotine Tob Res 2017; 19: 1185-1191.
Case K. R., Lazard A. J., Mackert M. S., Perry C. L. Source credibility and e-cigarette attitudes: implications for tobacco communication. Health Commun 2018; 33: 1059-1067.
Katz S. J., Lindgren B., Hatsukami D. E-cigarettes warning labels and modified risk statements: tests of messages to reduce recreational use. Tob Regul Sci 2017; 3: 445-458.
Kimber C., Frings D., Cox S., Albery I. P., Dawkins L. Communicating the relative health risks of E-cigarettes: an online experimental study exploring the effects of a comparative health message versus the EU nicotine addiction warnings on smokers' and non-smokers' risk perceptions and behavioural intentions. Addict Behav 2020; 101: 106177.
Lee H.-Y., Lin H.-C., Seo D.-C., Lohrmann D. K. The effect of e-cigarette warning labels on college students' perception of e-cigarettes and intention to use e-cigarettes. Addict Behav 2018; 76: 106-112.
Mays D., Smith C., Johnson A. C., Tercyak K. P., Niaura R. S. An experimental study of the effects of electronic cigarette warnings on young adult nonsmokers' perceptions and behavioral intentions. Tob Induc Dis 2016; 14: 17.
Owusu D., Weaver S. R., Yang B., Ashley D. L., Popova L. Trends in Trust in the Sources of health information on E-cigarettes among US adults, 2015-2017. Am J Public Health 2019; 109: 145-147.
Pepper J. K., Squiers L. B., Peinado S. C., Bann C. M., Dolina S. D., Lynch M. M., et al. Impact of messages about scientific uncertainty on risk perceptions and intentions to use electronic vaping products. Addict Behav 2019; 91: 136-140.
Popova L., Ling P. M. Nonsmokers' responses to new warning labels on smokeless tobacco and electronic cigarettes: an experimental study. BMC Public Health 2014; 14: 997.
Rohde J. A., Noar S. M., Prentice-Dunn H., Kresovich A., Hall M. G. Comparison of message and effects perceptions for the real cost E-cigarette prevention ads. Health Commun 2020; 35: 1-9.
Sanders-Jackson A., Schleicher N. C., Fortmann S. P., Henriksen L. Effect of warning statements in e-cigarette advertisements: an experiment with young adults in the United States. Addiction 2015; 110: 2015-2024.
Tattan-Birch H., Jackson S. E., Ide C., Bauld L., Shahab L. Evaluation of the impact of a regional educational advertising campaign on harm perceptions of e-cigarettes, prevalence of e-cigarette use, and quit attempts among smokers. Nicotine Tob Res 2019; 22: 1148-1154.
Vereen R. N., Westmaas J. L., Bontemps-Jones J., Jackson K., Alcaraz K. I. Trust of Information about tobacco and E-cigarettes from health professionals versus tobacco or electronic cigarette companies: differences by subgroups and implications for tobacco messaging. Health Commun 2020; 35: 89-95.
Weaver S. R., Jazwa A., Popova L., Slovic P., Rothenberg R. B., Eriksen M. P. Worldviews and trust of sources for health information on electronic nicotine delivery systems: effects on risk perceptions and use. SSM-Popul Health 2017; 3: 787-794.
Yang B., Liu J., Popova L. Targeted versus nontargeted communication about electronic nicotine delivery Systems in Three Smoker Groups. Int J Environ Res Public Health 2018; 15: 2071.
Yang B., Liu J., Popova L. Feeling hopeful motivates change: emotional responses to messages communicating comparative risk of electronic cigarettes and combusted cigarettes. Health Educ Behav 2019; 46: 471-483.
Yang B., Owusu D., Popova L. Testing messages about comparative risk of electronic cigarettes and combusted cigarettes. Tob Control 2019; 28: 440-448.
Yang B., Owusu D., Popova L. Effects of a nicotine fact sheet on perceived risk of nicotine and E-cigarettes and intentions to seek information about and use E-cigarettes. Int J Environ Res Public Health 2020; 17: 131.
Yang B., Spears C. A., Popova L. Psychological distress and responses to comparative risk messages about electronic and combusted cigarettes. Addict Behav 2019; 91: 141-148.
Alcalá H. E., Shimoga S. V., It I. About trust: Trust in Sources of tobacco health information, perceptions of harm, and use of E-cigarettes. Nicotine Tob Res 2019; 22: 822-826.
Wackowski O. A., Hammond D., O'Connor R. J., Strasser A. A., Delnevo C. D. Considerations and future research directions for E-cigarette warnings-findings from expert interviews. Int J Environ Res Public Health 2017; 14: 781.
Wackowski O. A., O'Connor R. J., Strasser A. A., Hammond D., Villanti A. C., Delnevo C. D. Smokers' and e-cigarette users' perceptions of modified risk warnings for e-cigarettes. Prev Med Rep 2016; 4: 309-312.
Gravely S., Driezen P., Ouimet J., Quah A. C., Cummings K. M., Thompson M. E., et al. Prevalence of awareness, ever-use and current use of nicotine vaping products (NVPs) among adult current smokers and ex-smokers in 14 countries with differing regulations on sales and marketing of NVPs: cross-sectional findings from the ITC project. Addiction 2019; 114: 1060-1073.
Yong H.-H., Borland R., Balmford J., Hitchman S. C., Cummings K. M., Driezen P., et al. Prevalence and correlates of the belief that electronic cigarettes are a lot less harmful than conventional cigarettes under the different regulatory environments of Australia and the United Kingdom. Nicotine Tob Res 2017; 19: 258-263.
Campbell M., McKenzie J. E., Sowden A., Katikireddi S. V., Brennan S. E., Ellis S., et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 2020; 368: 1.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605.
Soar K., Dawkins L., Robson D., Cox S. Smoking amongst adults experiencing homelessness: a systematic review of prevalence rates, interventions and the barriers and facilitators to quitting and staying quit. J Smoking Cessation 2020; 15: 94-108.

Auteurs

Daniel A Erku (DA)

Centre for Applied Health Economics, Griffith University, Nathan, QLD, Australia.
Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia.
School of Pharmacy, The University of Queensland, 20 Cornwall Street, Woolloongabba, QLD, 4102, Australia.

Linda Bauld (L)

Usher Institute and SPECTRUM Consortium, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh, Edinburgh, Scotland, EH8 9AG, UK.

Lynne Dawkins (L)

Centre for Addictive Behaviours Research, School of Applied Sciences, London South Bank University, 103 Borough Road, London, UK.

Coral E Gartner (CE)

School of Public Health, The University of Queensland, Herston Road, Herston, QLD, 4006, Australia.
Queensland Alliance for Environmental Health Sciences, The University of Queensland, 20 Cornwall Street, Woolloongabba, QLD, 4102, Australia.

Kathryn J Steadman (KJ)

School of Pharmacy, The University of Queensland, 20 Cornwall Street, Woolloongabba, QLD, 4102, Australia.

Seth M Noar (SM)

Hussman School of Journalism and Media, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-3365, USA.

Shakti Shrestha (S)

School of Pharmacy, The University of Queensland, 20 Cornwall Street, Woolloongabba, QLD, 4102, Australia.

Kylie Morphett (K)

School of Public Health, The University of Queensland, Herston Road, Herston, QLD, 4006, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH